Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher
tabling member	label

Search

1124211

	human indexable
	published
	registered interest
	answer date	08/05/2019
	date	01/05/2019
	date tabled	01/05/2019
	ddp created	01/05/2019 18:12:18
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/05/2019 14:25:07 08/05/2019 14:28:01
	hansard heading	WHO Framework Convention on Tobacco Control
	house id	1
	identifier	249956
	legislature	25259
	parliament number	57
	question first answered	08/05/2019 13:56:24
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the FCTC 2030 group of countries implement the provisions of the World Health Organization Framework Convention on Tobacco Control relating to the tobacco track and trace system.
	session	2017/19
	session number	1
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	title	House of Commons Tabled Parliamentary Question 2017/19 249956
	type	WrittenParliamentaryQuestion
	uin	249956
	version	3
	written parliamentary question type	NamedDay
	answer	answer
	creator	4488 label Biography information for Martyn Day
	publisher	25259
	tabling member	4488 label Biography information for Martyn Day

1125739

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	09/05/2019
	date tabled	09/05/2019
	ddp created	09/05/2019 17:01:22
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/05/2019 17:10:42 17/05/2019 13:06:04
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	252468
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 12:34:07
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has plans to involve patient organisations in setting the success factors for the 2019 Voluntary Scheme for Branded Medicines Pricing and Access as part of the first operational review meeting.
	session	2017/19
	session number	1
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	title	House of Commons Tabled Parliamentary Question 2017/19 252468
	type	WrittenParliamentaryQuestion
	uin	252468
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	151 label Biography information for Tom Brake
	publisher	25259
	tabling member	151 label Biography information for Tom Brake

1127772

	human indexable
	published
	registered interest
	answer date	23/05/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:40:30
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 17:55:35 30/05/2019 11:24:02
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	257056
	legislature	25259
	parliament number	57
	question first answered	30/05/2019 10:52:06
	question text	To ask the Secretary of State for Health and Social Care, whether the review of the methods for the NICE Technology Appraisal Programme referred to in the 2019 voluntary scheme for branded medicines pricing and access will include support for earlier patient access to innovative medicines.
	session	2017/19
	session number	1
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	title	House of Commons Tabled Parliamentary Question 2017/19 257056
	type	WrittenParliamentaryQuestion
	uin	257056
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4398 label Biography information for Chris Green
	publisher	25259
	tabling member	4398 label Biography information for Chris Green

1132140

	human indexable
	published
	registered interest
	answer date	18/06/2019
	date	13/06/2019
	date tabled	13/06/2019
	ddp created	13/06/2019 17:16:35
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	13/06/2019 17:32:16 18/06/2019 17:11:01
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	264409
	legislature	25259
	parliament number	57
	question first answered	18/06/2019 16:39:17
	question text	To ask the Secretary of State for Health and Social Care, what progress NHS England has made on developing a commercial framework in relation to the Voluntary Pricing and Access Scheme for branded medicines.
	session	2017/19
	session number	1
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	title	House of Commons Tabled Parliamentary Question 2017/19 264409
	type	WrittenParliamentaryQuestion
	uin	264409
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4249 label Biography information for Anne Marie Morris
	publisher	25259
	tabling member	4249 label Biography information for Anne Marie Morris

1139442

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:34:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:43:37 22/07/2019 16:18:06
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	277757
	legislature	25259
	parliament number	57
	question first answered	22/07/2019 15:46:12
	question text	To ask the Secretary of State for Health and Social Care, with reference to the 2019 Voluntary Scheme for Branded Medicines Pricing and Access, how many opportunities there have been for pharmaceutical industry trade bodies to input into NHS England’s commercial framework; and what steps the Government is taking to secure the participation of industry trade bodies.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 277757
	type	WrittenParliamentaryQuestion
	uin	277757
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259
	tabling member	4382 label Biography information for Daniel Zeichner

1110785

	human indexable
	published
	registered interest
	answer date	15/04/2019
	date	09/04/2019
	date tabled	09/04/2019
	ddp created	09/04/2019 20:17:36
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/04/2019 20:55:40 15/04/2019 13:44:23
	hansard heading	Visual Impairment: Surgery
	house id	1
	identifier	242748
	legislature	25259
	parliament number	57
	question first answered	15/04/2019 13:00:52
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 April 2019 to Question 239205 on Ophthalmology, if his Department will publish the (a) data and (b) analysis on which NHS Improvement based the assessment that indicates that Minimally Invasive Glaucoma Surgery (MIGS) is cheaper than other glaucoma procedures; and what the difference is in reference costs for MIGS and cataract operation since the last tariff prices were set.
	session	2017/19
	session number	1
	tabling member constituency	Dudley North
	tabling member printed	Ian Austin
	title	House of Commons Tabled Parliamentary Question 2017/19 242748
	type	WrittenParliamentaryQuestion
	uin	242748
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	1511 label Biography information for Lord Austin of Dudley
	publisher	25259
	tabling member	1511 label Biography information for Lord Austin of Dudley

1127674

	human indexable
	published
	registered interest
	answer date	22/05/2019
	date	20/05/2019
	date tabled	20/05/2019
	ddp created	20/05/2019 21:03:59
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	20/05/2019 21:13:50 29/05/2019 11:35:02
	hansard heading	Vegetables: Children
	house id	1
	identifier	256416
	legislature	25259
	parliament number	57
	question first answered	29/05/2019 11:03:20
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage children to eat green vegetables.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 256416
	type	WrittenParliamentaryQuestion
	uin	256416
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4131 label Biography information for Jim Shannon
	publisher	25259
	tabling member	4131 label Biography information for Jim Shannon

1121453

	human indexable
	published
	registered interest
	answer date	24/04/2019
	date	11/04/2019
	date tabled	11/04/2019
	ddp created	11/04/2019 18:14:58
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	11/04/2019 18:43:33 24/04/2019 08:40:05
	hansard heading	Vaccination: Research
	house id	1
	identifier	244039
	legislature	25259
	parliament number	57
	question first answered	24/04/2019 08:08:02
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution on 26 March 2019 to Question 910028 on Antimicrobial Resistance: Vaccines, what steps his Department is taking to stimulate research and development into vaccines, including for tuberculosis, as an alternative to antibiotics.
	session	2017/19
	session number	1
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	title	House of Commons Tabled Parliamentary Question 2017/19 244039
	type	WrittenParliamentaryQuestion
	uin	244039
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	1439 label Biography information for Norman Lamb
	publisher	25259
	tabling member	1439 label Biography information for Norman Lamb

1121454

	human indexable
	published
	registered interest
	answer date	24/04/2019
	date	11/04/2019
	date tabled	11/04/2019
	ddp created	11/04/2019 18:15:01
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	11/04/2019 18:43:35 24/04/2019 08:40:02
	hansard heading	Vaccination: Research
	house id	1
	identifier	244040
	legislature	25259
	parliament number	57
	question first answered	24/04/2019 08:08:03
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution on 26 March 2019 to Question 910028 on Antimicrobial Resistance: Vaccines, what funding he plans to make to stimulate research and development into vaccines as an alternative to antibiotics.
	session	2017/19
	session number	1
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	title	House of Commons Tabled Parliamentary Question 2017/19 244040
	type	WrittenParliamentaryQuestion
	uin	244040
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	1439 label Biography information for Norman Lamb
	publisher	25259
	tabling member	1439 label Biography information for Norman Lamb

1123111

	human indexable
	published
	registered interest
	answer date	29/04/2019
	date	25/04/2019
	date tabled	25/04/2019
	ddp created	25/04/2019 16:57:48
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	25/04/2019 17:08:12 03/05/2019 13:43:02
	hansard heading	Vaccination: Disinformation
	house id	1
	identifier	247635
	legislature	25259
	parliament number	57
	question first answered	03/05/2019 13:11:25
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle misinformation in anti-vaccine literature.
	session	2017/19
	session number	1
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	title	House of Commons Tabled Parliamentary Question 2017/19 247635
	type	WrittenParliamentaryQuestion
	uin	247635
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1447 label Biography information for Andrew Rosindell
	publisher	25259
	tabling member	1447 label Biography information for Andrew Rosindell